Citation Tools
PDFHealth economics
Original research
Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis